In the era of genomics, should tumor size be reconsidered as a criterion for neoadjuvant chemotherapy?
Pivot X, Mansi L, Chaigneau L, Montcuquet P, Thiery-Vuillemin A, Bazan F, Dobi E, Sautiere JL, Rigenbach F, Algros MP, Butler S, Jamshidian F, Febbo P, Svedman C, Paget-Bailly S, Bonnetain F, Villanueva C.
Pivot X, et al. Among authors: villanueva c.
Oncologist. 2015 Apr;20(4):344-50. doi: 10.1634/theoncologist.2014-0198. Epub 2015 Mar 20.
Oncologist. 2015.
PMID: 25795632
Free PMC article.
Clinical Trial.